课题基金 / 基金详情

Role of HS1 in Actin Regulation During T Cell Activation

Role of HS1 in Actin Regulation During T Cell Activation
HS1 在 T 细胞激活过程中肌动蛋白调节中的作用
批准号:
7064354
负责人:
TIMOTHY S GOMEZ
金额:
$3.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-02-01 至 2006-11-21

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):旨在理解T细胞激活过程中利用的信号转导机制的努力为开发药物或基因操纵T细胞的策略提供了基础。肌动蛋白细胞骨架在T细胞活化和功能中起关键作用,被认为在免疫突触(is)组织淋巴细胞信号复合物。该领域的一个主要研究焦点是Wiskott- Aldrich综合征蛋白(WASp),它在T细胞活化中起着明确的作用。然而,最近的数据表明,在IS上形成F-actin可能不需要WASp,因此必须有其他机制促成这一现象。该应用程序的重点是白细胞特异性的同源物,HS1,一种结合肌动蛋白和Arp2/3复合物的多域信号分子。虽然HS1在体外调节f -肌动蛋白聚合,但尚未确定HS1在控制淋巴细胞肌动蛋白重组中的功能作用。我们的初步数据表明,在T细胞激活过程中,HS1是F-actin在is积累所必需的。因此,我们假设HS1与已知的肌动蛋白调控蛋白(包括Vav1和Itk)合作,在T细胞活化过程中重组肌动蛋白细胞骨架。
英文摘要
DESCRIPTION (provided by applicant): Efforts aimed at understanding the signal transduction mechanisms utilized during T cell activation provide a foundation for developing strategies to pharmacologically or genetically manipulate T cells. The actin cytoskeleton plays a key role in T cell activation and function and is thought to organize lymphocyte signaling complexes at the immunological synapse (IS). A major focus of research in this area has been the Wiskott- Aldrich Syndrome protein (WASp), which plays a clear role in T cell activation. However, recent data suggest that WASp may not be required for the formation of F-actin at the IS, so other mechanisms must contribute to this phenomenon. This application focuses on the leukocyte-specific homologue of Cortactin, HS1, a multi-domain signaling molecule that binds actin and the Arp2/3 Complex. Although HS1 regulates F-actin polymerization in vitro, no functional role for HS1 in controlling actin reorganization in lymphocytes has been established. Our preliminary data demonstrate that HS1 is required for the accumulation of F-actin at the IS during T cell activation. Therefore, we hypothesize that HS1 cooperates with the known actin- regulatory proteins, including Vav1 and Itk, to reorganize the actin cytoskeleton during T cell activation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
吞噬受体SLAMF7通过激活HS1促进巨噬细胞抗肿瘤免疫的机制研究
  • 批准号:
    82071745
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    陈俊
  • 依托单位:
一氧化碳释放分子对脓毒症血小板活化关键信号分子HS1磷酸化及其调节激酶的干预与分子机制
  • 批准号:
    81071546
  • 项目类别:
    面上项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2010
  • 负责人:
    孙炳伟
  • 依托单位: